Cellectis SA logo

Cellectis SA

XPAR:ALCLS (France)  
€ 1.48 (-1.33%) Dec 24
At Loss
P/B:
1.29
Market Cap:
€ 148.14M ($ 154.46M)
Enterprise V:
€ -14.65M ($ -15.27M)
Volume:
29.29K
Avg Vol (2M):
48.05K
Trade In:
Volume:
29.29K
At Loss
Avg Vol (2M):
48.05K

Business Description

Description
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
Name Current Vs Industry Vs History
Cash-To-Debt 2.85
Equity-to-Asset 0.33
Debt-to-Equity 0.71
Debt-to-EBITDA -1.54
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.4
Distress
Grey
Safe
Beneish M-Score -4.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 11.68
9-Day RSI 20.76
14-Day RSI 27.7
6-1 Month Momentum % -1.37
12-1 Month Momentum % -42.47

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.78
Quick Ratio 1.78
Cash Ratio 1.57
Days Sales Outstanding 95.73
Days Payable 40309.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.8
Shareholder Yield % -83.54

Financials (Next Earnings Date:2025-02-04 Est.)

XPAR:ALCLS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cellectis SA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 26.511
EPS (TTM) (€) -1.229
Beta 3.11
Volatility % 47.38
14-Day RSI 27.7
14-Day ATR (€) 0.078357
20-Day SMA (€) 1.7244
12-1 Month Momentum % -42.47
52-Week Range (€) 1.414 - 3.158
Shares Outstanding (Mil) 100.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cellectis SA Filings

Filing Date Document Date Form
No Filing Data

Cellectis SA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Cellectis SA Frequently Asked Questions

What is Cellectis SA(XPAR:ALCLS)'s stock price today?
The current price of XPAR:ALCLS is €1.48. The 52 week high of XPAR:ALCLS is €3.16 and 52 week low is €1.41.
When is next earnings date of Cellectis SA(XPAR:ALCLS)?
The next earnings date of Cellectis SA(XPAR:ALCLS) is 2025-02-04 Est..
Does Cellectis SA(XPAR:ALCLS) pay dividends? If so, how much?
Cellectis SA(XPAR:ALCLS) does not pay dividend.

Press Release

Subject Date
No Press Release